DUN'S 100 - 2016

409 / 730

409
2016 | DUN’S 100 DUN’S 100 | 2015
DUN’S 100 | 2016 2016 | DUN’S 100
Business Services
Law Firms - High-Tech
Horn Co. is the leading Israeli boutique
law firm in the field of hi-tech and life sci-
ences, and is unique in its exclusive prac-
tice and expertise in this field. The firm’s founder,
Yuval Horn, was recognized by the International
Who’sWho of Life Sciences Lawyers as one of the
five leading individuals in the world in life sciences
transactions in 2013, and again in 2015.
Horn &Co.’s expertise includes the representation
of clients in all aspects of their operations, includ-
ing especially their technology and intellectual
property transactions, their corporate and funding
matters and their commercial contracting.
Horn & Co. was founded in September 2009 and
is known for its tailored, innovative structures, so-
lutions and advice in complex transactions and
situations. Horn&Co.’s practice in the life sciences
area began in 1994, when Yuval Horn represented
Orgenics Ltd. in its sale toSelfCare, Inc. Since then,
both Yuval and his colleagues have represented
numerous founders, companies and investors in
their transactions in the life science and technol-
ogy sectors. Recent examples from 2015 include
the representation of Ccam Biotherapeutics Ltd.
in its sale to Merck & Co., Inc. in the largest cash
based transaction in 2015 in the Israeli life sci-
ences field; the representation of
Ltd. in the largest private financing round of an
Israeli company (of over $120 million) in 2015;
and the formation of Pontifax 4 L.P., the fourth
fund of Pontifax Venture Capital group, Israel’s
most prominent life sciences designated invest-
ment fund.
Horn & Co. is the Israeli member of Biolegis (www.
, a network of leading European
law firms with specific expertise in the repre-
sentation of biotechnology and medical device
companies.
The firm’s partners and associates have been rec-
ognized by the leading international publications
and peers as experts in corporate law, intellec-
tual property and technology transactions and are
typically asked to lecture and write about these
areas. Yuval has been recognized as an expert in
life sciences by the InternationalWho’sWho Legal:
Life Sciences during the years 2008-2015. Since
2008 he has been a member and legal advisor
of the Institutional Review Board (Helsinki Com-
mittee) of the ChaimSheba Medical Center at Tel-
Hashomer, Israel’s largest medical facility. Yuval
currently serves as the Co-Chair of the International
Bar Association (IBA) Technology Law Committee,
and is amember of the Executive Committee of the
IBA Annual World Life Sciences Conference.
Corporate
Horn & Co. has vast experience in the representa-
tion of biotechnology, medical device, software,
telecommunications, and cleantech companies.
The firm’s corporate clients include companies of
all sizes, from Israeli based incubator companies
to multinational companies conducting business
in Israel.
Intellectual Property Transactions
Horn &Co. has particular expertise in life sciences,
medical devices, internet, software, telecommu-
nications and cleantech. The firm was recently
selected by IAM Magazine as one of the top 6
recommended Israeli firms in the field of licens-
ing and defined as a “uniquely focused ensemble
[which] caters almost exclusively to clients within
the life sciences sector”. With a thorough under-
standing of the specific complexities and needs
of technology-based, long-haul development com-
panies, the firm represents clients in all aspects
of strategic transactions. Recent transactions in-
cluded the representation of Intec Pharma Ltd.
(TASE; NASDAQ) in its licensing agreement with
Biogen, dozens of agreements with technology
transfer companies, and the services and license
agreement between ZebraMedicalVision Ltd. and
Dell Services.
Mergers & Acquisitions
The firm has a substantial track-record in repre-
sentation of purchasers and targets in private and
publicmerger and acquisition transactions, and is
widely experienced in private and public mergers
includes the involvement and advice in reverse
mergers, mergers into publicly traded shells, asset
purchases and share acquisitions. Some recent
examples are the representation of cCamBiothera-
peutics Ltd. in its sale to Merck & Co. Inc., Cellera
Technologies, Inc. in its asset sale to Elron, and
Babylon Software Ltd. in the purchase of assets
of Babylon Ltd.
Regulation
Horn & Co. regularly advises international and Is-
raeli companies with respect to their relationships
with the Office of the Chief Scientist in the Israeli
Ministry of Economy, and assists in structuring both
local and cross-borders technology transactions so
to adequately conform to applicable regulations
and lawful requirements. The firm has advised
several multinational companies with respect to
the incorporation and setting up of businesses in
Israel, as well as their relationships with the Office
of the Chief Scientist of the Ministry of Economy,
and theMinistry of Health. Horn & Co. is the Israeli
member of TRACE .
org) and is responsible for the Israeli chapter on
anti-corruption issues in the international publica-
tion “Getting the Deal Through”.
Securities and Capital Markets
Horn & Co. regularly advises Israeli and inter-
national clients on their full range of corporate
finance transactions. Horn & Co. has special expe-
rience in registration and issuance of securities of
technology companies on USand Israeli securities
exchanges, including IPOs, follow-on offerings and
PIPEs. Horn & Co. was recently ranked as a leading
firm in the area of capital markets by IFLR1000.
Venture Capital
Horn & Co. advises companies, founders, govern-
ment funded incubators, private investors and ven-
ture capital funds with respect to their full range
of finance transactions, including seed rounds,
venture capital funding, venture lending, strategic
partner investments andmergers and acquisitions.
Our close acquaintance with both company and
investor needs and limitations further enables us
to provide a unique view and expertise to transac-
tions. We have been involved in the formation of
venture capital funds, and regularly advise such
funds with respect to their relationships with their
limited partners.
Horn & Co. Law Offices
Esta b l i s h e d
2009
L i n e o f B u s i n ess
Hi-Tech, M&A, IP, Capital Market law
pa rt n e r s
Keren Kanir
Roy Ribon
Ohad Mamann
Orly Sternfeld
2 Weizmann St., Amot Investments Tower
24 floor, Tel Aviv 6423902
Tel: 972-3-637-8200
Fax: 972-3-637-8201
Yuval Horn
Founding Partner *
* See Top Executives Profiles - Page 582